BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15623596)

  • 1. Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer.
    Tamborini E; Bonadiman L; Negri T; Greco A; Staurengo S; Bidoli P; Pastorino U; Pierotti MA; Pilotti S
    Clin Cancer Res; 2004 Dec; 10(24):8214-9. PubMed ID: 15623596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
    Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
    Krystal GW; Hines SJ; Organ CP
    Cancer Res; 1996 Jan; 56(2):370-6. PubMed ID: 8542594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new strategy for treating small cell lung cancer].
    Ueda R; Takashi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():111-4. PubMed ID: 9216197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
    Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.
    Tamborini E; Miselli F; Negri T; Lagonigro MS; Staurengo S; Dagrada GP; Stacchiotti S; Pastore E; Gronchi A; Perrone F; Carbone A; Pierotti MA; Casali PG; Pilotti S
    Clin Cancer Res; 2006 Dec; 12(23):6920-8. PubMed ID: 17145809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
    Pedersen M; Rönnstrand L; Sun J
    Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
    Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
    Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
    Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
    Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.
    Tamborini E; Papini D; Mezzelani A; Riva C; Azzarelli A; Sozzi G; Pierotti MA; Pilotti S
    Br J Cancer; 2001 Aug; 85(3):405-11. PubMed ID: 11487273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene.
    Sekido Y; Takahashi T; Ueda R; Takahashi M; Suzuki H; Nishida K; Tsukamoto T; Hida T; Shimokata K; Zsebo KM
    Cancer Res; 1993 Apr; 53(7):1709-14. PubMed ID: 7680956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD117+ small cell lung cancer lacks the asp 816-->val point mutation in exon 17.
    Mojica WD; Saxena R; Starostik P; Cheney RT
    Histopathology; 2005 Nov; 47(5):517-22. PubMed ID: 16242000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
    Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
    Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.
    Krug LM; Crapanzano JP; Azzoli CG; Miller VA; Rizvi N; Gomez J; Kris MG; Pizzo B; Tyson L; Dunne M; Heelan RT
    Cancer; 2005 May; 103(10):2128-31. PubMed ID: 15812822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.
    DiPaola RS; Kuczynski WI; Onodera K; Ratajczak MZ; Hijiya N; Moore J; Gewirtz AM
    Cancer Gene Ther; 1997; 4(3):176-82. PubMed ID: 9171936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer.
    Hibi K; Takahashi T; Sekido Y; Ueda R; Hida T; Ariyoshi Y; Takagi H; Takahashi T
    Oncogene; 1991 Dec; 6(12):2291-6. PubMed ID: 1722571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma.
    Lagonigro MS; Tamborini E; Negri T; Staurengo S; Dagrada GP; Miselli F; Gabanti E; Greco A; Casali PG; Carbone A; Pierotti MA; Pilotti S
    J Pathol; 2006 Apr; 208(5):615-23. PubMed ID: 16470538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs).
    Negri T; Bozzi F; Conca E; Brich S; Gronchi A; Bertulli R; Fumagalli E; Pierotti MA; Tamborini E; Pilotti S
    J Pathol; 2009 Jan; 217(1):103-12. PubMed ID: 18973210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
    Uccini S; Mannarino O; McDowell HP; Pauser U; Vitali R; Natali PG; Altavista P; Andreano T; Coco S; Boldrini R; Bosco S; Clerico A; Cozzi D; Donfrancesco A; Inserra A; Kokai G; Losty PD; Nicotra MR; Raschellà G; Tonini GP; Dominici C
    Clin Cancer Res; 2005 Jan; 11(1):380-9. PubMed ID: 15671569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.